| Course | NU 636 Advanced Pharmacology |
|---|---|
| Unit | Unit 6 |
| Paper type | Discussion post with peer reply |
| Length | About 450 words, 3 pages |
| Format | Discussion post, APA 7 citations |
| School | Herzing University |
| Program | MSN Family Nurse Practitioner |
| Updated | October 2026 |
Free sample paper for NU 636 Unit 6
Unit 6 Discussion: Initial Post and Peer Reply
Nifedipine, Not Lisinopril, for a 31-Year-Old With Chronic Hypertension Who Is Planning Pregnancy
Initial Post
For the patient in this week's prompt, a 31-year-old woman with stage 2 chronic hypertension (average home readings 152/96) who plans to conceive within the next year, I would start nifedipine extended release 30 mg by mouth once daily.
The obvious alternative is lisinopril, which is inexpensive, once daily, and a first-line agent for hypertension in nonpregnant adults. The factor that removes it is the pregnancy plan written into the prompt. Angiotensin-converting enzyme inhibitors are fetotoxic in the second and third trimesters, causing fetal kidney injury, oligohydramnios, and skull ossification defects, and a cohort study of first-trimester exposure also reported an increased risk of major congenital malformations (Cooper et al., 2006), although later studies have questioned how much of that risk is due to the drug rather than to hypertension itself. With conception planned and many pregnancies unplanned in timing, starting an agent that must be stopped the moment she conceives builds a hazard into the plan. Nifedipine extended release and labetalol are the agents recommended for chronic hypertension in pregnancy (American College of Obstetricians and Gynecologists [ACOG], 2019), so starting one of them now means no switch is needed at conception.
Treating to a lower target in pregnancy is also now supported. In the Chronic Hypertension and Pregnancy trial, treating mild chronic hypertension to below 140/90 reduced a composite of adverse pregnancy outcomes without increasing small-for-gestational-age births (Tita et al., 2022).
Monitoring: home blood pressure twice daily, reviewed at two and four weeks, with the dose increased to 60 mg if readings remain above 140/90; ankle swelling and headache are the adverse effects I would ask about at each check. Question for the group: would you choose labetalol over nifedipine for this patient, and on what factor?
Reply to Classmate
I want to test your choice of labetalol for the same patient rather than agree with it. The factor I think your post did not weigh is dosing frequency. Labetalol's short half-life usually requires dosing two or three times daily, and in a young woman who works full time, a twice or three times daily regimen is a real adherence risk, especially as doses rise in later pregnancy. Both labetalol and nifedipine are listed as appropriate first-line options (ACOG, 2019), so the evidence does not force either choice; practical factors decide. Labetalol would be the better choice if she had a history of migraine with tachycardia or if she developed troublesome edema on nifedipine. Is there a reason in her history, such as asthma, that you weighed and I missed? That would push me away from labetalol even further, because it is a nonselective beta blocker.
References
American College of Obstetricians and Gynecologists. (2019). ACOG practice bulletin no. 203: Chronic hypertension in pregnancy. Obstetrics & Gynecology, 133(1), e26-e50. https://doi.org/10.1097/AOG.0000000000003020
Cooper, W. O., Hernandez-Diaz, S., Arbogast, P. G., Dudley, J. A., Dyer, S., Gideon, P. S., Hall, K., & Ray, W. A. (2006). Major congenital malformations after first-trimester exposure to ACE inhibitors. New England Journal of Medicine, 354(23), 2443-2451. https://doi.org/10.1056/NEJMoa055202
Tita, A. T., Szychowski, J. M., Boggess, K., Dugoff, L., Sibai, B., Lawrence, K., Hughes, B. L., Bell, J., Aagaard, K., Edwards, R. K., Gibson, K., Haas, D. M., Plante, L., Metz, T., Casey, B., Esplin, S., Longo, S., Hoffman, M., Saade, G. R., ... Andrews, W. W. (2022). Treatment for mild chronic hypertension during pregnancy. New England Journal of Medicine, 386(19), 1781-1792. https://doi.org/10.1056/NEJMoa2201295
The Herzing NU 636 Unit 6 instructions
The Unit 6 discussion asks you to answer a prescribing question about a patient in the prompt and then respond to classmates. Expect the initial post to name a specific drug and dose early, then justify it with patient factors and evidence. Medication safety considerations, such as pregnancy planning, kidney function or interactions, are usually central. Replies must add substance: test a classmate's choice, raise a factor they missed or bring a new source. Scholarly citations are required in the post and replies, in APA form, and many sections require recent guidelines. Word counts and posting days are set in the classroom, with an early deadline for the first post in many sections. Keep the tone professional, and when you disagree, address the reasoning instead of the person.
Inside the NU 636 Unit 6 example
The initial post opens with a direct recommendation and dose so the reader knows the answer in the first sentence. It then explains why lisinopril, a common first choice, is avoided in someone planning pregnancy, citing evidence on fetal risk from exposure. Nifedipine is supported by obstetric guidance and by a trial showing benefit from treating chronic hypertension during pregnancy. The post sets a blood pressure target and a follow-up interval. The reply to a classmate opens by saying it will test their choice of labetalol, then explains that labetalol's short half-life usually requires dosing two or three times daily, which can reduce adherence in a busy young adult. It acknowledges labetalol as a reasonable alternative and ends with a question that keeps the discussion moving. Three sources support the post and reply together.
Where the points sit in the NU 636 Unit 6 rubric
Herzing discussion rubrics generally mark the initial post for accuracy, application to the case, evidence and clarity, with replies judged on substance and engagement. Accuracy points require correct drug information and safety considerations. Application credit depends on a recommendation that grows out of this patient's details, here pregnancy planning, instead of a general answer. Evidence points go to current guidelines and studies cited in the post. Reply points depend on adding a new consideration or testing a classmate's reasoning with support. Timeliness and participation across more than one day are frequently separate criteria. Clarity covers professional writing and a direct structure. A reply that respectfully challenges a classmate's choice with a reason and a citation tends to earn more than one that simply agrees.
NU 636 Unit 6 help before you submit
Pharmacology posts often lose points by discussing a drug class without naming a specific agent and dose. Students also overlook the key safety issue in the prompt, such as pregnancy planning, and recommend a drug that should be avoided. Replies that agree with a classmate's choice and restate it add nothing. Missing citations, or citations to general websites, cost evidence points. Another frequent problem is long background on hypertension before the recommendation appears. Late first posts lose points automatically in many sections. When disagreeing, some writers sound dismissive, which affects the professionalism score. Finally, include monitoring and a follow-up interval, even briefly, because a prescribing answer without them is incomplete for an FNP level discussion.
Get a NU 636 Unit 6 example written to your instructions
Send the Unit 6 instructions and the rubric from your NU 636 classroom, along with the prompt wording and the reply requirement. We write a custom example post and reply against those criteria, committing to an agent with an interval and a rejected alternative, and return it in 24 to 48 hours. The first custom sample is free.
More NU 636 papers and FNP samples
- NU 636 Unit 1: Drug class profile
- NU 636 Unit 2: Prescribing rationale
- NU 636 Unit 3: Pharmacotherapy plan
- NU 636 Unit 4: Patient education handout
- NU 636 Unit 5: Drug therapy paper
- NU 636 Unit 7: Drug comparison paper
- NU 636 Unit 8: Comprehensive case study
- NU 632 Unit 6: Adolescent confidentiality and consent plan
- NU 610 Unit 6: Documentation critique
- NU 611 Unit 6: Case presentation
- NU 621 Unit 6: Clinical correlation paper
NU 636 Unit 6 questions, answered
How does a pharmacology post differ from a pathophysiology one?
A pathophysiology post is scored on the chain from cause to observable finding, so hedging about mechanism is the failure. A pharmacology post is scored on a decision, so refusing to choose is the failure. The same writer often carries habits from one into the other, producing an elegant explanation of a drug class that never says which agent this patient should receive.
What makes a reply worth full credit here?
A challenge with evidence behind it. Naming a factor the original post did not weigh, an interaction it missed or a population where its choice would be unsafe, then citing something current, does more in three sentences than a paragraph of agreement. Ask a question the writer can answer from the literature, which keeps the thread working rather than closing it.
Do I need current sources for a discussion post?
Yes, and currency matters more in this course than in most. Dosing, safety and interaction guidance is revised, so a citation that was solid a few years ago may no longer describe practice. Confirm any publication window your instructions set, then pick references you could defend if an instructor asked why you trusted that recommendation.
Where can I find a free NU 636 Unit 6 sample paper?
The NU 636 Unit 6 post and reply are both on this page free, with the nifedipine recommendation, the reasoning against lisinopril and the citations. If your discussion prompt is about a different patient, send it and a custom post with reply comes back at no cost, generally by the next day or the one after.
Why avoid lisinopril in a woman planning pregnancy?
Angiotensin-converting enzyme inhibitors are linked to fetal harm, particularly later in pregnancy, so guidelines advise against them for people planning to conceive. Nifedipine extended release or labetalol are commonly preferred, with the choice depending on dosing and patient factors.